Bone marrow-derived immune cells mediate sensitization to liver injury in a myeloid differentiation factor 88-dependent fashion

Hepatology

Volumn 48, Issue 4, 2008, Pages 1342-1347

  Hritz, Istvan ^a,b   Velayudham, Arumugam ^a   Dolganiuc, Angela ^a   Kodys, Karen ^a   Mandrekar, Pranoti ^a   Kurt Jones, Evelyn ^a   Szabo, Gyongyi ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; BACTERIUM LIPOPOLYSACCHARIDE; GREEN FLUORESCENT PROTEIN; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 9; LIPOPOLYSACCHARIDE; MYD88 PROTEIN, MOUSE; TLR2 PROTEIN, MOUSE; TLR9 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW; CELL INFILTRATION; CHIMERA; CONTROLLED STUDY; FEMALE; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; INFLAMMATION; INFLAMMATORY CELL; LIVER CELL; LIVER INJURY; LIVER PARENCHYMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; PROTEIN EXPRESSION; SENSITIZATION; SIGNAL TRANSDUCTION; ANIMAL; BONE MARROW CELL; CYTOLOGY; GENETICS; GRANULOMA; LIVER DISEASE; METABOLISM; MICROBIOLOGY; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY;

ANIMALS; BONE MARROW CELLS; CHIMERA; FEMALE; GRANULOMA; GREEN FLUORESCENT PROTEINS; INFLAMMATION; LIPOPOLYSACCHARIDES; LIVER DISEASES; MICE; MICE, KNOCKOUT; MYELOID DIFFERENTIATION FACTOR 88; PROPIONIBACTERIUM ACNES; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 9;

EID: 54449102395     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.22557     Document Type: Article

References (25)

1. Williams R. Classification, etiology, and considerations of outcome in liver failure. Semin Liver Dis 1996;16:343-348.
2. Pasare C, Medzhitov R. Toll-like receptors: Linking innate and adaptive immunity. Adv Exp Med Biol 2005;560:11-18.
3. Zarember KA, Godowski PJ. Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J Immunol 2002; 168:554-561.
4. Szabo G, Dolganiuc A, Mandrekar P. Pattern recognition receptors: A contemporary view on liver diseases. HEPATOLOGY 2006;44:287-298.
5. Kawai T, Akira S. TLR signaling. Semin Immunol 2007;19:24-32.
6. O'Neill LA, Bowie AG. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nature Rev Immunol 2007;7:353-364.
7. Seki E, Tsutsui H, Iimuro Y, Naka T, Son G, Akira S, et al. Contribution of Toll-like receptor/myeloid differentiation factor 88 signaling to murine liver regeneration. HEPATOLOGY 2005;41:443-450.
8. Campbell JS, Riehle KJ, Brooling JT, Bauer RL, Mitchell C, Fausto N. Proinflammatory cytokine production in liver regeneration is Myd88-dependent, but independent of CD14, TLR2, and TLR4. J Immunol 2006; 176:2522-2528.
9. Chen YL, Yu CK,, Lei HY. Propionibacterium acnes induces acute TNFalpha-mediated apoptosis of hepatocytes followed by inflammatory T-cell-mediated granulomatous hepatitis in mice. J Biomed Sci 1999;6:349-356.
10. Kalis C, Gumenscheimer M, Freudenberg N, Tchaptchet S, Fejer G, Heit A, et al. Requirement for TLR9 in the immunomodulatory activity of Propionibacterium acnes. J Immunol 2005;174:4295-4300.
11. Romics L Jr, Dolganiuc A, Velayudham A, Kodys K, Mandrekar P, Golenbock D, et al. Toll-like receptor 2 mediates inflammatory cytokine induction but not sensitization for liver injury by Propionibacterium acnes. J Leukoc Biol 2005;78:1255-1264.
12. Velayudham A, Hritz I, Dolganiuc A, Mandrekar P, Kurt-Jones E, Szabo G. Critical role of toll-like receptors and the common TLR adaptor, MyD88, in induction of granulomas and liver injury. J Hepatol 2006;45: 813-824.
13. Tsuji H, Mukaida N, Harada A, Kaneko S, Matsushita E, Nakanuma Y, et al. Alleviation of lipopolysaccharide-induced acute liver injury in Propionibacterium acnes-primed IFN-gamma-deficient mice by a concomitant reduction of TNF-alpha, IL-12, and IL-18 production. J Immunol 1999; 162:1049-1055.
14. Shimizu Y, Margenthaler JA, Landeros K, Otomo N, Doherty G, Flye MW. The resistance of P. acnes-primed interferon gamma-deficient mice to low-dose lipopolysaccharide-induced acute liver injury. HEPATOLOGY 2002;35:805-814.
15. Romics L Jr, Dolganiuc A, Kodys K, Drechsler Y, Oak S, Velayudham A, et al. Selective priming to Toll-like receptor 4 (TLR4), not TLR2, ligands by P. acnes involves up-regulation of MD-2. HEPATOLOGY 2004;40:555-564.
16. Iizasa H, Yoneyama H, Mukaida N, Katakoka Y, Naito M, Yoshida N, et al. Exacerbation of granuloma formation in IL-1 receptor antagonist-deficient mice with impaired dendritic cell maturation associated with Th2 cytokine production. J Immunol 2005;174:3273-3280.
17. Karrar A, Broome U, Sodergren T, Jaksch M, Bergquist A, Bjornstedt M, et al. Biliary epithelial cell antibodies link adaptive and innate immune responses in primary sclerosing cholangitis. Gastroenterology 2007;132: 1504-1514.
18. Martin-Armas M, Simon-Santamaria J, Pettersen I, Moens U, Smedsrod B, Sveinbjornsson B. Toll-like receptor 9 (TLR9) is present in murine liver sinusoidal endothelial cells (LSECs) and mediates the effect of CpG-oligonucleotides. J Hepatol 2006;44:939-946.
19. Moritoki Y, Lian ZX, Wulff H, Yang GX, Chuang YH, Lan RY, et al. AMA production in primary biliary cirrhosis is promoted by the TLR9 ligand CpG and suppressed by potassium channel blockers. HEPATOLOGY 2007;45:314-322.
20. Ito T, Schaller M, Hogaboam CM, Standiford TJ, Chensue SW, Kunkel SL. TLR9 activation is a key event for the maintenance of a mycobacterial antigen-elicited pulmonary granulomatous response. Eur J Immunol 2007;37:2847-2855.
21. Mathurin P, Deng QG, Keshavarzian A, Choudhary S, Holmes EW, Tsukamoto H. Exacerbation of alcoholic liver injury by enteral endotoxin in rats. HEPATOLOGY 2000;32:1008-1017.
22. Dolganiuc A, Norkina O, Kodys K, Catalano D, Bakis G, Marshall C, et al. Viral and host factors induce macrophage activation and loss of toll-like receptor tolerance in chronic HCV infection. Gastroenterology 2007;133: 1627-1636.
23. Balagopal A, Philp FH, Astemborski J, Block TM, Mehta A, Long R, et al. Human immunodeficiency virus-related microbial translocation and progression of hepatitis C. Gastroenterology 2008;135:226-233.
24. Klune JR, Dhupar R, Cardinal J, Billiar TR, Tsung A. HMGB1: Endogenous danger signaling. Mol Med 2008;14:476-484.
25. Barrat FJ, Coffman RL. Development of TLR inhibitors for the treatment of autoimmune diseases. Immunol Rev. 2008;223:271-283.